ImportRefusal LogoImportRefusal

Suzhou Lixin Pharmaceutical Co. Ltd.

⚠️ Moderate Risk

FEI: 3008251350 • Suzhou, Jiangsu • CHINA

FEI

FEI Number

3008251350

📍

Location

Suzhou, Jiangsu

🇨🇳

Country

CHINA
🏢

Address

21 Tangxi Road, , Suzhou, Jiangsu, China

Moderate Risk

FDA Import Risk Assessment

43.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

13
Total Refusals
5
Unique Violations
2/10/2021
Latest Refusal
1/12/2005
Earliest Refusal

Score Breakdown

Violation Severity
73.0×40%
Refusal Volume
42.5×30%
Recency
1.6×20%
Frequency
8.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

22004×

DIET INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be for use as an ingredient in a dietary supplement and appears to be or may be otherwise unfit for food.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

Refusal History

DateProductViolationsDivision
2/10/2021
53YH99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C.
471CSTIC LBLG
75UNAPPROVED
Division of West Coast Imports (DWCI)
9/26/2016
54YBR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
4/15/2016
54YYR99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
16DIRECTIONS
75UNAPPROVED
Los Angeles District Office (LOS-DO)
5/12/2015
54YYS99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2200DIET INGRE
75UNAPPROVED
Los Angeles District Office (LOS-DO)
12/18/2014
53PY99OTHER COSMETIC RAW MATERIALS, N.E.C.
471CSTIC LBLG
New Orleans District Office (NOL-DO)
6/11/2014
66VCR99MISCELLANEOUS PATENT MEDICINES, ETC.
2200DIET INGRE
75UNAPPROVED
Los Angeles District Office (LOS-DO)
7/6/2011
66VCS99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Cincinnati District Office (CIN-DO)
1/25/2011
54YBS99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2200DIET INGRE
Los Angeles District Office (LOS-DO)
1/25/2011
54YBS08COENZYME Q10 (VIT/MIN/PROTEIN/UNCONVENTIONAL DIETARY SPEC FOR HUMAN/ANIMAL, N.E.C.)
2200DIET INGRE
Los Angeles District Office (LOS-DO)
11/15/2010
66BIY99STIMULANT N.E.C.
118NOT LISTED
16DIRECTIONS
Cincinnati District Office (CIN-DO)
6/3/2005
66VCR99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/16/2005
64BCZ25HYDROCHLOROTHIAZIDE (DIURETIC)
118NOT LISTED
75UNAPPROVED
Los Angeles District Office (LOS-DO)
1/12/2005
66VAS99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Suzhou Lixin Pharmaceutical Co. Ltd.'s FDA import refusal history?

Suzhou Lixin Pharmaceutical Co. Ltd. (FEI: 3008251350) has 13 FDA import refusal record(s) in our database, spanning from 1/12/2005 to 2/10/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Suzhou Lixin Pharmaceutical Co. Ltd.'s FEI number is 3008251350.

What types of violations has Suzhou Lixin Pharmaceutical Co. Ltd. received?

Suzhou Lixin Pharmaceutical Co. Ltd. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Suzhou Lixin Pharmaceutical Co. Ltd. come from?

All FDA import refusal data for Suzhou Lixin Pharmaceutical Co. Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.